Rappler's latest stories on Melissa Guerrero
A majority of the medicines covered by the new EO involve illnesses that often hit the elderly, like diabetes and hypertension
Economist Hilton Lam once conducted an economic evaluation of Dengvaxia, which showed the vaccine is only cost-effective if sold at P654.25 each. The DOH bought the vaccine at P1,000 each.
How are LGUs faring in the delivery of better health outcomes and greater access to medicines?